Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus

about

Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus

Item

http://www.wikidata.org/entity/Q58602192

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Better surgical treatment meth ...... ith portal vein tumor thrombus

@en

Better surgical treatment meth ...... ith portal vein tumor thrombus

@nl

type

Item

label

Better surgical treatment meth ...... ith portal vein tumor thrombus

@en

Better surgical treatment meth ...... ith portal vein tumor thrombus

@nl

prefLabel

Better surgical treatment meth ...... ith portal vein tumor thrombus

@en

Better surgical treatment meth ...... ith portal vein tumor thrombus

@nl

P1476

Better surgical treatment meth ...... ith portal vein tumor thrombus

@en

P2093

Bin Xu

http://www.w3.org/2001/XMLSchema#string

Cong-Yun Huang

http://www.w3.org/2001/XMLSchema#string

De-Fei Hong

http://www.w3.org/2001/XMLSchema#string

Jiang-Tao Li

http://www.w3.org/2001/XMLSchema#string

Shu-You Peng

http://www.w3.org/2001/XMLSchema#string

Xu-An Wang

http://www.w3.org/2001/XMLSchema#string

Yi-Fang Wang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma

Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation.

P304

4527-4535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

editorial

P356

10.3748/WJG.V24.I40.4527

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386102

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

hepatocellular carcinoma

P932

6209573

http://www.w3.org/2001/XMLSchema#string